Henriette Burghoorn

Henriette Burghoorn is an accomplished professional in Market Access with extensive experience in the pharmaceutical industry. Currently serving as Associate Director at Gilead Sciences since June 2017, Henriette has led Global Value & Access initiatives and managed market access strategies for liver-related products in Midsized Markets. Prior experience includes roles at MSD Netherlands, where responsibilities encompassed market access management for primary care and oncology, as well as the development of medical affairs strategies focusing on diabetes and cardiology. Additionally, Henriette has worked at Roche bv as a Clinical Project Manager, Kendle International Inc. as a Clinical Research Associate, and the Public Health Research Institute as a Research Associate. Henriette holds multiple degrees, including an MSc in Management from the University of Greenwich and Het Van Hall Instituut, and a BSc in Medical/Plants-lab technology from HTS.